The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
Open accessAbstract
Chromosomal translocations involving the MLL gene occur in about 80% of infant leukemia. In the search for possible agents inducing infant leukemia, we identified bioflavonoids, natural substances in food as well as in dietary supplements, that cause site-specific DNA cleavage in the MLL breakpoint cluster region (BCR) in vivo . The MLL BCR DNA cleavage was shown in primary progenitor hematopoietic cells from healthy newborns and adults as well as in cell lines; it colocalized with the MLL BCR cleavage site induced by chemotherapeutic agents, such as etoposide (VP16) and doxorubicin (Dox). Both in vivo and additional in vitro experiments demonstrated topoisomerase II (topo II) as the target of bioflavonoids similar to VP16 and Dox. Based on 20 bioflavonoids tested, we identified a common structure essential for topo II-induced DNA cleavage. Reversibility experiments demonstrated a religation of the bioflavonoid as well as the VP16-induced MLL cleavage site. Our observations support a two-stage model of cellular processing of topo II inhibitors: The first and reversible stage of topo II-induced DNA cleavage results in DNA repair, but also rarely in chromosome translocations; whereas the second, nonreversible stage leads to cell death because of an accumulation of DNA damage. These results suggest that maternal ingestion of bioflavonoids may induce MLL breaks and potentially translocations in utero leading to infant and early childhood leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
Liu, L. F. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002031 · Cited by 1,811
Ferry, D., Smith, A., Malkhandi, J., Fyfe, D. W., DeTakats, P., Anderson, D., Baker, J., & Kerr, R. S. (1996) · PubMed · Cited by 769
Plasma concentrations of phyto-oestrogens in Japanese men
ADLERCREUTZ, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92188-y · Cited by 731
Gale, K. B., Ford, A. M., Repp, R., Borkhardt, A., Keller, C., Eden, O. B., & Greaves, M. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13950 · Cited by 551
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin‐Sablon, A., Saucier, J.-M., Pecq, J. B. L., & Larsen, A. K. (1989) · PubMed · Cited by 550
Greaves, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09412-3 · Cited by 504
In utero rearrangements in the trithorax-related oncogene in infant leukaemias
Ford, A. M., Ridge, S. A., Cabrera, M. E., Mahmoud, H., Steel, C. M., Chan, L. C., & Greaves, M. (1993) · Nature · doi:10.1038/363358a0 · Cited by 456
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397
Self-citationHydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans
Bokkenheuser, V. D., Shackleton, C. H., & Winter, J. (1987) · Biochemical Journal · doi:10.1042/bj2480953 · Cited by 340
Quantification of genistein and genistin in soybeans and soybean products
Fukutake, M., Takahashi, M., Ishida, K., Kawamura, H., Sugimura, T., & Wakabayashi, K. (1996) · Food and Chemical Toxicology · doi:10.1016/0278-6915(96)87355-8 · Cited by 296
Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992
Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson, R. K., & Robison, L. L. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00004 · Cited by 276
HPLC Analysis of Isoflavonoids and Other Phenolic Agents from Foods and from Human Fluids
Franke, A. A., Custer, L. J., Wang, W., & Shi, C. Y. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44231 · Cited by 248
Constantinou, A. I., Kiguchi, K., & Huberman, E. (1990) · PubMed · Cited by 223
Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., & Robison, L. L. (1996) · Cancer Causes and Control · doi:10.1007/bf00051700 · Cited by 219
Yoshinori, Y., Sho-Zou, K., & Hirofumi, N. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90153-c · Cited by 215
Bioavailability of the dietary antioxidant flavonol quercetin in man
Hollman, P. C. H., van Trijp, J. M. P., Mengelers, M. J. B., de Vries, J. H. M., & Katan, M. B. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04644-2 · Cited by 209
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia
Relling, M., Yanishevski, Y., Nemec, J., Evans, W., Boyett, J., Behm, F., & Pui, C.-H. (1998) · Leukemia · doi:10.1038/sj.leu.2400928 · Cited by 188
Stanulla, M., Wang, J., Chervinsky, D. S., Thandla, S., & Aplan, P. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4070 · Cited by 178
Epidemiology of Childhood Leukemia, with a Focus on Infants
Ross, J. A., Davies, S. M., Potter, J. D., & Robison, L. L. (1994) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036153 · Cited by 178
Käs, E., & Laemmli, U. K. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05103.x · Cited by 176
Austin, C. A., Patel, S., Ono, K., Nakane, H., & Fisher, L. M. (1992) · Biochemical Journal · doi:10.1042/bj2820883 · Cited by 170
Strissel, P. L., Strick, R., Rowley, J. D., & Zeleznik‐Le, N. J. (1998) · Blood · doi:10.1182/blood.v92.10.3793 · Cited by 165
Self-citationAplan, P., Chervinsky, D., Stanulla, M., & Burhans, W. (1996) · Blood · doi:10.1182/blood.v87.7.2649.bloodjournal8772649 · Cited by 165
Sorensen, P. H., Chen, C. S., Smith, F. O., Arthur, D. C., Domer, P. H., Bernstein, I. D., Korsmeyer, S. J., Hammond, G. D., & Kersey, J. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116978 · Cited by 161
Burden, D. A., Kingma, P. S., Froelich-Ammon, S. J., Bjornsti, M., Patchan, M. W., Thompson, R. B., & Osheroff, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29238 · Cited by 149
Infant Leukemia, Topoisomerase II Inhibitors, and the MLL Gene
Ross, J. A., Potter, J. D., & Robison, L. L. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1678 · Cited by 147
Nilson, I., Lochner, K., Siegler, G. M., Greil, J., Beck, J. D., Fey, G. H., & Marschalek, R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1748.x · Cited by 127
Super, H. J. G., Rothberg, P., Kobayashi, H., Ai, F., Diaz, M., & Rowley, J. (1994) · Blood · doi:10.1182/blood.v83.3.641.641 · Cited by 105
Self-citationDomer, P. H., Head, D. R., Renganathan, N., Raimondi, S. C., Yang, E., & Atlas, M. (1995) · PubMed · Cited by 95
Robinson, M. J., Corbett, A. H., & Osheroff, N. (1993) · Biochemistry · doi:10.1021/bi00065a016 · Cited by 94
Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons
Hsiang, Y. H., & Liu, L. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81711-2 · Cited by 85
Record, I. R., Broadbent, J. L., King, R. A., Dreosti, I. E., Head, R. J., & Tonkin, A. (1997) · International Journal of Cancer · Cited by 67
Ritke, M. K., Roberts, D., Allan, W., Raymond, J., Bergoltz, V. V., & Yalowich, J. C. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.131 · Cited by 67
Complete exon structure of the ALL1 gene.
Rasio, D., Schichman, S. A., Negrini, M., et al. (1996) · PubMed · Cited by 67
Synthetic flavonoids cross the placenta in the rat and are found in fetal brain
der Elst, J. P. S.-V., van der Heide, D., Rokos, H., de Escobar, G. M., & Köhrle, J. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.2.e253 · Cited by 62
Même, W., Huchet, C., & Léoty, C. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c253 · Cited by 40
Analysis of the region of the 5' end of the MLL gene involved in genomic duplication events
Wiedemann, L. M., MacGregor, A., & Caldas, C. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01291.x · Cited by 15
Cited by
D IETARY F LAVONOIDS: Bioavailability, Metabolic Effects, and Safety
Ross, J. A., & Kasum, C. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.111401.144957 · Cited by 2,151
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
I NHIBITION OF C ARCINOGENESIS BY D IETARY P OLYPHENOLIC C OMPOUNDS
Yang, C. S., Landau, J. M., Huang, M.-T., & Newmark, H. L. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.381 · Cited by 1,260
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
“Finally, it is important to mention several reports showing that specific concentrations of luteolin may produce toxic effects [205, 210, 238-240].”
BackgroundApigenin: A Promising Molecule for Cancer Prevention
Shukla, S., & Gupta, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0089-7 · Cited by 820
Metadata
- Authors
- Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., & Rowley, J. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-04-11
- Volume
- 97
- Issue
- 9
- Pages
- 4790-4795
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2155089093
- Cited by
- 390
- References
- 37
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.